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determine the origins of epidermal papillomas. Using histological studies and transgene expression as a marker for papilloma development, we determined that pedunculated papillomas arose from focal hyperplaslas of the permanent portion of the follicular epithelium in phorbol 12-myristate 13-acetatetreated TG.AC mouse skin. Damage to the hair follicle by depilation was also sufcient to induce papillomas that were histologically ind uishable from those produced by chemical exposure. Identcation of the cellular origins of papiflomas in this transgenic mouse model will allow for an analysis of the role of the hair follicle and hair cycle-associated signaling in tumor development.
The cellular targets for chemical carcinogens in the skin are believed to be epithelial stem cells (1) , which occur in both the interfollicular epithelial and the follicular epithelia (2, 3) . Several lines of research have produced evidence suggesting that skin tumors in both humans and animal models arise from the stem cells ofthe hair follicle (4) (5) (6) (7) (8) (9) (10) (11) (12) . The hair follicle is a complex organ composed of several distinct epithelial cell types associated with a dermal papilla and sebaceous gland (13) , which cycles from a state of actively growing hair (anagen) to a regressive state (catagen) to a resting state (telogen) (14) . Growth factors and cell adhesion molecules play important roles in signaling between the dermal papilla and the follicular epithelia that regulate the growth and cycling of the hair follicle (13, (15) (16) (17) (18) (19) (20) . Recent evidence suggests that a population ofouter root sheath epithelial cells may be the stem cells of the hair follicle and that follicles entering anagen (which is associated with proliferation of these cells) are more sensitive to chemical carcinogenesis (3, 12, 21) . These "bulge" region stem cells, situated between the sebaceous gland and the insertion site for the arector pili muscle, have been proposed as the progenitor cells for some skin tumors (3) . A model for the identification of follicular papilloma precursors at an early stage would allow the cellular origins and effects of hair cycle specific signals on tumor development to be investigated. A transgenic mouse model for skin carcinogenesis has been developed, which is particularly well suited to address the questions surrounding the very early events of tumorigenesis. This line is the v-Ha-ras transgenic TG.AC mouse, which was created by Leder et al. in FVB/N mice (22) . TG.AC mice develop extremely few spontaneous dorsal skin tumors when housed singly (22, 23) . However, they rapidly respond to either wounding or treatment with chemicals such as phorbol 12-myristate 13-acetate (PMA) by forming epidermal papillomas that overexpress the v-Ha-ras transgene (22) (23) (24) . Additionally, in several respects such as protein kinase C activity, hyperplasia, and the focal nature of papilloma development, the response of the TG.AC mice to tumor promoters is indistinguishable from that of chemically initiated nontransgenic FVB/N mice (22, 24 (Promega) . Approximately equal incorporation of the radiolabel was found for the antisense and sense riboprobes.
In Situ Hybridization. Pieces of dorsal skin or skin tumor were removed from TG.AC and nontransgenic FVB/N mice and fixed in 4% (wt/vol) paraformaldehyde. After processing and embedding in paraffin, -4-,um sections were placed on Superfrost plus slides (Fisher), and in situ hybridization was performed using the 35S-labeled Riboprobe. The in situ hybridization assay is described in Hansen and Tennant (24) and was adapted from Newbold et al. (25) . Controls for these experiments included assaying serial sections of tissues with both sense and antisense probes and using nontransgenic FVB/N tissues as negative controls. Proliferating Cell Nuclear Antigen (PCNA) Immunohls tochemistry. Pieces of dorsal skin or skin tumor were removed from TG.AC and nontransgenic FVB/N mice, fixed Abbreviations: PMA, phorbol 12-myristate 13-acetate; PCNA, proliferating cell nuclear antigen. *To whom reprint requests should be addressed.
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in 4% paraformaldehyde, processed, embedded in paraffin, and sectioned. PCNA immunohistochemistry was performed as described (24, 26) 
RESULTS AND DISCUSSION
The v-Ha-ras transgenic TG.AC mouse line develops very few spontaneous dorsal skin tumors when housed singly and rapidly responds to either wounding or treatment with chemicals such as the tumor promoter PMA by forming epidermal papillomas (22, 23) . Eighteen days from the start of PMA treatment (8 days after the final application), the earliest histologically observable lesions in TG.AC mouse skin appeared as focal hyperplasias of the permanent portion of the hair follicle (Fig. 1A) . At 18-19 days the hyperplasias usually involved only the upper region of a single hair follicle from just below the bottommost edge of the sebaceous gland to the epidermis ( Fig. 1 A and B) . By 21 days from the start of treatment, lesions were generally larger and protruded from the surface of the epidermis (Fig. 1C) . By 25 days the now macroscopically visible lesions often appeared to involve several hyperplastic hair follicles and palpably protruded above the surface of the skin (Fig. 1D) . Between 18 and 32 days, lesions generally increased in size, and by 32 days pedunculated papillomas predominated (Fig. 1E) Previous experiments have shown that the overexpression of the v-Ha-ras transgene is a marker for benign and malignant skin tumors but is not overexpressed in non-tumorbearing TG.AC skin (24) . As shown in Fig. 2 , the v-Ha-ras mRNA was localized to a region of the upper follicle in focal follicular hyperplasias removed from TG.AC mouse skin. No transgene expression was detected in the surrounding interfollicular epidermis or nonhyperplastic follicles (Fig. 2) . A pattern of expression of the transgene in the permanent portion of the hyperplastic follicles, but not the surrounding interfollicular epidermis or follicle bulb, was consistently seen in early lesions. In papilloma precursors, which ap- Removal of the hair by plucking induces anagen and proliferation in the follicular epithelium of nontransgenic mice (27, 28) . Since the follicular cells proliferate as hair follicles cycle into anagen (12) , we hypothesized that plucking would induce proliferation and a regenerative hyperplasia in the stem cells and promote tumor development from these cells in the TG.AC mice. Dorsal hair was removed from groups of TG.AC mice by using a warm wax depilatory or by tweezing. Single or multiple biweekly applications of a wax depilatory were sufficient to induce papillomas in TG.AC skin (Fig. 3) . Papillomas arose as early as 6 weeks, with more than five papillomas per mouse by 20 (Fig.  4 and ref. 24) . Some papillomas progressed to malignancies diagnosed histologically as either squamous cell carcinomas or sarcomas, although the mice were not held for an extended period of time to allow for the development of malignancies. Removal of TG.AC hair by tweezing also induced papilloma development (data not shown).
Identification of follicular cells as the progenitor cells of papillomas suggests that an understanding of the dermal and epithelial signals regulating hair growth and the proliferation of cells of the follicle associated with entry into anagen might lead to a better understanding of the events involved in skin tumor development. Localized and cycle-specific expression of growth factors in the hair follicle (17) (18) (19) (20) (29) (30) (31) , dermal messages essential to follicular development (13, 15, 16) , and an anagen-specific activation ofthe bulge cells (12) (lanes 1 and 2) , or dorsal epidermis from untreated nontransgenic FVB/N controls (lanes 3 and 4) immunoprecipitated using an anti-Ha-ras antibody and Western blotted with an antibody preferentially specific for v-Ha-ras p21 as previously (24) . Lanes 9 and 10 were loaded with 100 jg of homogenate protein from v-Ha-ras-and wild-type c-Ha-ras-overexpressing cell lines, respectively. on these events remain to be determined, although it is known that PMA can alter the hair cycle by inducing proliferation of hair follicles, which progress from catagen or telogen to late anagen (11) .
The evidence we present that papillomas arise in TG.AC mice from follicular cells does not preclude the possibility that some papillomas, in TG.AC or nontransgenic mice, may derive from a different group of cells in the interfollicular epidermis. Indeed, the identification of two populations of stem cells, one in the bulge area (3) and one in the epidermal proliferative unit of the interfollicular epidermis (2), as well as other evidence illustrating that both interfollicular epidermal cells and hair follicle cells transformed by v-Ha-ras produce papillomas when grafted onto nude mice (32) , suggests that tumors might arise from either compartment. While the bulge area, which has been implicated as a site for follicular stem cells, is located in the permanent portion ofthe hair follicle (3), as are the follicular hyperplasias detected in TG.AC mouse skin, our results do not allow the origins of the papillomas to be categorically identified as bulge stem cells.
Development of papillomas from hair follicles in nontransgenic mice has been suggested to be the result of greater exposure of the hair follicle to the initiating agent (33) . Our results with the TG.AC mice suggest that greater exposure of follicles to initiating agents is not solely responsible for the development of papillomas with a follicular origin but that factors intrinsic to follicles are also involved. Alternatively, the follicular origin of papillomas in the transgenic TG.AC mice might result from the constitutive low level expression of the v-Ha-ras transgene in follicular cells but not the interfollicular epidermis. However, a solely follicular constitutive expression ofthe transgene does not appear to be likely based on preliminary results using reverse transcription followed by PCR on the scraped surface epidermis from TG.AC skin (C. Trempus and L.A.H., unpublished observations). Overexpression of the fetal C-globin-promoted transgene in specific follicular cells during papilloma development probably occurs at least partly as a consequence of the site of transgene integration (22 (23) supports the idea that the cells may be sensitive to induction of the transgene in a cell cycle-dependent manner.
Much remains to be understood about the signaling environment and cells of the hair follicle that might increase our understanding of the mechanisms of tumorigenesis in the skin. In this regard, the v-Ha-ras transgenic TG.AC mouse line offers distinct advantages. First, we have demonstrated the identification of very early lesions at least in part due to the sensitive, almost synchronous response of these mice to tumor promoters like PMA. Secondly, the ras transgene acts as a marker for the tumor progenitor cells since it is consistently overexpressed in papillomas and preneoplastic hyperplasias but not in non-tumor-bearing TG.AC skin. These factors illustrate the possibility of studying interactions between ras activation and signals related to follicular signaling pathways in vivo. Finally, the striking similarities between TG.AC skin and nontransgenic chemically initiated mouse skin (24) mean that this transgenic line is appropriate for investigating the early events of skin tumorigenesis.
